The Inhibition of Bromodomain and Extraterminal Domain (BET) Proteins Protects Against Microglia-Mediated Neuronal Loss In Vitro
Biomolecules · 04.04.2025 · 15 (4) · 528
DOI: 10.3390/biom15040528 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, online erschienen am 04.04.2025. Verfasst von Marta Matuszewska und 4 weiteren Autor:innen. Beteiligte Einrichtung: Mossakowski Medical Research Institute, Polish Academy of Sciences, Department of Cellular Signalling, ul. Pawińskiego 5, 02-106 Warsaw, Poland. Hauptthemen laut MEDLINE: Microglia, Triazoles, Azepines, Neurons. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Centre, The National Science Centre, Poland.
Abstract (Originalsprache)
Neuroinflammation is a key feature of all neurodegenerative disorders, including Alzheimer’s disease, and is tightly regulated by epigenetic mechanisms. Among them, bromodomain and extraterminal domain (BET) proteins play a crucial role by recognizing acetylated histones and acting as transcriptional co-regulators to modulate gene expression. This study investigates the potential of inhibiting BET proteins in preventing microglia-mediated neuronal damage in vitro. Murine BV2 microglial cells were exposed to lipopolysaccharide (LPS) or amyloid-β (Aβ) to induce an inflammatory response, and the subsequent effects on murine HT22 neuronal cells were examined. Among the BET proteins tested, only Brd4 was significantly upregulated in BV2 cells upon pro-inflammatory stimulation. JQ1, a potent pan-inhibitor of BET proteins, suppressed LPS-induced upregulation of pro-inflammatory cytokine mRNA levels, including Il1b, Il6, and Tnf, in BV2 microglia. Pre-treatment with JQ1 attenuated the cytotoxicity of LPS-activated BV2 cells toward neurons. Additionally, conditioned media from Aβ fibril-stimulated BV2 cells induced neuronal cell death, which was partially prevented by pre-treatment with JQ1. Co-culture assays further demonstrated the beneficial effect of BET inhibition. Our findings suggest that targeting BET proteins may offer a neuroprotective strategy by modulating microglial activation, potentially providing therapeutic benefits in neurodegenerative diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Mossakowski Medical Research Institute, Polish Academy of Sciences, Department of Cellular Signalling, ul. Pawińskiego 5, 02-106 Warsaw, Poland.
- University of Warsaw, Faculty of Chemistry, ul. Pasteura 1, 02-093 Warsaw, Poland.
ORCID-Profile: Anna Wilkaniec, Magdalena Cieślik, Marcin Strawski, Grzegorz A Czapski
Förderung
- National Science Centre
- The National Science Centre, Poland
Zitieren
APA
Matuszewska, M., Wilkaniec, A., Cieślik, M., Strawski, M., & Czapski, G. A. (2025). The Inhibition of Bromodomain and Extraterminal Domain (BET) Proteins Protects Against Microglia-Mediated Neuronal Loss In Vitro. Biomolecules, 15(4), 528. https://doi.org/10.3390/biom15040528
Vancouver
Matuszewska M, Wilkaniec A, Cieślik M, Strawski M, Czapski GA. The Inhibition of Bromodomain and Extraterminal Domain (BET) Proteins Protects Against Microglia-Mediated Neuronal Loss In Vitro. Biomolecules. 2025;15(4):528. doi:10.3390/biom15040528
BibTeX
@article{Matuszewska2025,
author = {Matuszewska, Marta and Wilkaniec, Anna and Cieślik, Magdalena and Strawski, Marcin and Czapski, Grzegorz A},
title = {The Inhibition of Bromodomain and Extraterminal Domain (BET) Proteins Protects Against Microglia-Mediated Neuronal Loss In Vitro},
journal = {Biomolecules},
year = {2025},
volume = {15},
number = {4},
pages = {528},
doi = {10.3390/biom15040528}
}
EUVIMED